# Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)

> **NCT05868109** · PHASE2 · UNKNOWN · sponsor: **The Hospital for Sick Children** · enrollment: 40 (estimated)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** inhaled nitric oxide (iNO)
- **DRUG:** Sham

## Key facts

- **NCT ID:** NCT05868109
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-31
- **Primary completion:** 2025-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05868109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05868109, "Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05868109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*